Related Experiment Videos
[Apoptosis as a pathomechanism in sepsis]
S U Weber1, J-C Schewe, C Putensen
1Klinik und Poliklinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Bonn, Rheinische Friedrich-Wilhems-Universität. stefan.weber@ukb.uni-bonn.de
Der Anaesthesist
|January 30, 2004
Summary
Sepsis triggers increased programmed cell death in immune cells, particularly leukocytes. Targeting apoptosis regulators like Bcl-2 and caspases may improve survival in sepsis patients.
Area of Science:
- Immunology
- Cell Biology
- Pathophysiology
Context:
- Sepsis remains a primary cause of mortality in intensive care units.
- Complex immune system dysregulation characterizes sepsis pathophysiology.
- Recent studies highlight increased immune cell apoptosis during sepsis.
Purpose:
- To investigate the role of programmed cell death in sepsis.
- To explore the involvement of mitochondrial protein Bcl-2 and caspase cascades in sepsis-induced apoptosis.
- To evaluate the therapeutic potential of modulating apoptosis in sepsis.
Summary:
- Sepsis is associated with an elevated rate of programmed cell death, specifically apoptosis, in leukocytes.
- Both animal models and human patients with severe sepsis exhibit up-regulated leukocyte apoptosis.
- The mitochondrial protein Bcl-2 and the caspase cascade are key regulators of this apoptotic process.
Impact:
- Modulating Bcl-2 expression or inhibiting caspases enhances survival in sepsis animal models.
- These findings underscore the clinical relevance of apoptosis in severe sepsis.
- This research may lead to novel immunomodulatory therapeutic strategies for sepsis treatment.